Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?

by Pedro Weslley Rosario, Gabriela Franco Mourão

Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node...

by Pedro Weslley Rosario, Gabriela Franco Mourão, Maria Regina Calsolari
Published 2017-02-01

Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?

by Pedro Weslley Rosario, Gabriela Franco Mourão, Maria Regina Calsolari
Published 2015-01-01

Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies...

by Marina Carvalho S. Côrtes, Pedro Weslley Rosario, Gabriela Franco Mourão, Maria Regina Calsolari
Published 2018-07-01

Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion

by Pedro Weslley Rosario, Laura Sterian Ward, Hans Graf, Fernanda Vaisman, Gabriela Franco Mourão, Mario Vaisman

Antineutrophil cytoplasmic antibodies in patients treated with methimazole: a prospective Brazilian study

by Gabriela Costa Andrade, Flavia Coimbra Pontes Maia, Gabriela Franco Mourão, Pedro Weslley Rosario, Maria Regina Calsolari
Published 2019-09-01